Selected research
Industry Research
PVA Embolization Particles Industry Research Report 2026
Market perspective
The global PVA Embolization Particles market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for PVA Embolization Particles is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for PVA Embolization Particles is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for PVA Embolization Particles is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of PVA Embolization Particles include Boston Scientific Corporation, Terumo Corporation, Sirtex Medical, Merit Medical, INterface BIOmaterials, HENGRUI Medical, Cook Medical, BTG Medical and Alicon, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global PVA Embolization Particles market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
PVA Embolization Particles Market by Company
Boston Scientific Corporation
Terumo Corporation
Sirtex Medical
Merit Medical
INterface BIOmaterials
HENGRUI Medical
Cook Medical
BTG Medical
Alicon
PVA Embolization Particles Segment by Type
Conventional/Irregular PVA
Compressible and Spherical PVA
PVA Embolization Particles Segment by Application
Trauma Embolization
Liver Tumor Embolization
Prostatic Artery Embolization
Uterine Fibroid Embolization
Other
PVA Embolization Particles Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PVA Embolization Particles market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of PVA Embolization Particles and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PVA Embolization Particles.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of PVA Embolization Particles manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of PVA Embolization Particles by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of PVA Embolization Particles in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Conventional/Irregular PVA
- Compressible and Spherical PVA
Applications
- Trauma Embolization
- Liver Tumor Embolization
- Prostatic Artery Embolization
- Uterine Fibroid Embolization
- Other
Companies covered
- Boston Scientific Corporation
- Terumo Corporation
- Sirtex Medical
- Merit Medical
- INterface BIOmaterials
- HENGRUI Medical
- Cook Medical
- BTG Medical
- Alicon
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global PVA Embolization Particles Market Size (2021-2032)
- 2.2.2 Global PVA Embolization Particles Sales (2021-2032)
- 2.2.3 Global PVA Embolization Particles Market Average Price (2021-2032)
- 2.3 PVA Embolization Particles by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Conventional/Irregular PVA
- 2.3.3 Compressible and Spherical PVA
- 2.4 PVA Embolization Particles by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Trauma Embolization
- 2.4.3 Liver Tumor Embolization
- 2.4.4 Prostatic Artery Embolization
- 2.4.5 Uterine Fibroid Embolization
- 2.4.6 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global PVA Embolization Particles Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global PVA Embolization Particles Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global PVA Embolization Particles Revenue of Manufacturers (2021-2026)
- 3.4 Global PVA Embolization Particles Average Price by Manufacturers (2021-2026)
- 3.5 Global PVA Embolization Particles Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of PVA Embolization Particles, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of PVA Embolization Particles, Product Type & Application
- 3.8 Global Manufacturers of PVA Embolization Particles, Established Date
- 3.9 Global PVA Embolization Particles Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Boston Scientific Corporation
- 4.1.1 Boston Scientific Corporation Company Information
- 4.1.2 Boston Scientific Corporation Business Overview
- 4.1.3 Boston Scientific Corporation PVA Embolization Particles Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Boston Scientific Corporation PVA Embolization Particles Product Portfolio
- 4.1.5 Boston Scientific Corporation Recent Developments
- 4.2 Terumo Corporation
- 4.2.1 Terumo Corporation Company Information
- 4.2.2 Terumo Corporation Business Overview
- 4.2.3 Terumo Corporation PVA Embolization Particles Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Terumo Corporation PVA Embolization Particles Product Portfolio
- 4.2.5 Terumo Corporation Recent Developments
- 4.3 Sirtex Medical
- 4.3.1 Sirtex Medical Company Information
- 4.3.2 Sirtex Medical Business Overview
- 4.3.3 Sirtex Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sirtex Medical PVA Embolization Particles Product Portfolio
- 4.3.5 Sirtex Medical Recent Developments
- 4.4 Merit Medical
- 4.4.1 Merit Medical Company Information
- 4.4.2 Merit Medical Business Overview
- 4.4.3 Merit Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Merit Medical PVA Embolization Particles Product Portfolio
- 4.4.5 Merit Medical Recent Developments
- 4.5 INterface BIOmaterials
- 4.5.1 INterface BIOmaterials Company Information
- 4.5.2 INterface BIOmaterials Business Overview
- 4.5.3 INterface BIOmaterials PVA Embolization Particles Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 INterface BIOmaterials PVA Embolization Particles Product Portfolio
- 4.5.5 INterface BIOmaterials Recent Developments
- 4.6 HENGRUI Medical
- 4.6.1 HENGRUI Medical Company Information
- 4.6.2 HENGRUI Medical Business Overview
- 4.6.3 HENGRUI Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 HENGRUI Medical PVA Embolization Particles Product Portfolio
- 4.6.5 HENGRUI Medical Recent Developments
- 4.7 Cook Medical
- 4.7.1 Cook Medical Company Information
- 4.7.2 Cook Medical Business Overview
- 4.7.3 Cook Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Cook Medical PVA Embolization Particles Product Portfolio
- 4.7.5 Cook Medical Recent Developments
- 4.8 BTG Medical
- 4.8.1 BTG Medical Company Information
- 4.8.2 BTG Medical Business Overview
- 4.8.3 BTG Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 BTG Medical PVA Embolization Particles Product Portfolio
- 4.8.5 BTG Medical Recent Developments
- 4.9 Alicon
- 4.9.1 Alicon Company Information
- 4.9.2 Alicon Business Overview
- 4.9.3 Alicon PVA Embolization Particles Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Alicon PVA Embolization Particles Product Portfolio
- 4.9.5 Alicon Recent Developments
5 Global PVA Embolization Particles Market Scenario by Region
- 5.1 Global PVA Embolization Particles Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global PVA Embolization Particles Sales by Region: 2021-2032
- 5.2.1 Global PVA Embolization Particles Sales by Region: 2021-2026
- 5.2.2 Global PVA Embolization Particles Sales by Region: 2027-2032
- 5.3 Global PVA Embolization Particles Revenue by Region: 2021-2032
- 5.3.1 Global PVA Embolization Particles Revenue by Region: 2021-2026
- 5.3.2 Global PVA Embolization Particles Revenue by Region: 2027-2032
- 5.4 North America PVA Embolization Particles Market Facts & Figures by Country
- 5.4.1 North America PVA Embolization Particles Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America PVA Embolization Particles Sales by Country (2021-2032)
- 5.4.3 North America PVA Embolization Particles Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe PVA Embolization Particles Market Facts & Figures by Country
- 5.5.1 Europe PVA Embolization Particles Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe PVA Embolization Particles Sales by Country (2021-2032)
- 5.5.3 Europe PVA Embolization Particles Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific PVA Embolization Particles Market Facts & Figures by Country
- 5.6.1 Asia Pacific PVA Embolization Particles Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific PVA Embolization Particles Sales by Country (2021-2032)
- 5.6.3 Asia Pacific PVA Embolization Particles Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America PVA Embolization Particles Market Facts & Figures by Country
- 5.7.1 South America PVA Embolization Particles Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America PVA Embolization Particles Sales by Country (2021-2032)
- 5.7.3 South America PVA Embolization Particles Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa PVA Embolization Particles Market Facts & Figures by Country
- 5.8.1 Middle East and Africa PVA Embolization Particles Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa PVA Embolization Particles Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa PVA Embolization Particles Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global PVA Embolization Particles Sales by Type (2021-2032)
- 6.1.1 Global PVA Embolization Particles Sales by Type (2021-2032) & (k units)
- 6.1.2 Global PVA Embolization Particles Sales Market Share by Type (2021-2032)
- 6.2 Global PVA Embolization Particles Revenue by Type (2021-2032)
- 6.2.1 Global PVA Embolization Particles Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global PVA Embolization Particles Revenue Market Share by Type (2021-2032)
- 6.3 Global PVA Embolization Particles Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global PVA Embolization Particles Sales by Application (2021-2032)
- 7.1.1 Global PVA Embolization Particles Sales by Application (2021-2032) & (k units)
- 7.1.2 Global PVA Embolization Particles Sales Market Share by Application (2021-2032)
- 7.2 Global PVA Embolization Particles Revenue by Application (2021-2032)
- 7.2.1 Global PVA Embolization Particles Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global PVA Embolization Particles Revenue Market Share by Application (2021-2032)
- 7.3 Global PVA Embolization Particles Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 PVA Embolization Particles Value Chain Analysis
- 8.1.1 PVA Embolization Particles Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 PVA Embolization Particles Production Mode & Process
- 8.2 PVA Embolization Particles Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 PVA Embolization Particles Distributors
- 8.2.3 PVA Embolization Particles Customers
9 Global PVA Embolization Particles Analyzing Market Dynamics
- 9.1 PVA Embolization Particles Industry Trends
- 9.2 PVA Embolization Particles Industry Drivers
- 9.3 PVA Embolization Particles Industry Opportunities and Challenges
- 9.4 PVA Embolization Particles Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst